Status Of The E2007 (perampanel) Development Program E2007 (perampanel) is a first-in-class, orally administered, highly selective non-competitive AMPA-type glutamate receptor antagonist, in development by Eisai for several indications, including Parkinson's disease, neuropathic pain, epilepsy, multiple sclerosis and migraine prophylaxis. The AMPA receptor is widely present in almost all excitatory neuronal synapses.
Source: www.medicalnewstoday.comEntreMed To Highlight ENMD-2076 Kinase Inhibitor At 2008 AACR Annual Meeting EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced it will present preclinical data for its product candidates ENMD-2076, MKC-1, and ENMD-1198.
Source: www.medicalnewstoday.comTips To Protect Voice And Hearing As spring and summer bring an increase in outdoor activities, this is the right time of year to be more aware of speech and hearing issues. Typical recreational activities can increase exposure to potentially damaging problems.Experts in the audiology and speech pathology department at The Methodist Hospital in Houston have a few tips to keep your speech and hearing in working order.
Source: www.medicalnewstoday.comMajor Surgery No Longer Needed For The Removal Of Uterine Fibroids The treatment of uterine fibroids with 3T MR-guided focused ultrasound (MRgFUS) is safe, non-invasive and effective, according to a recent study conducted by researchers at Weill Cornell Medical College in New York, NY."Approximately 25% of women in the United States have clinically symptomatic fibroids, and treatment has most commonly been surgical with hysterectomy or myomectomy.
Source: www.medicalnewstoday.comExtremely Low Dose CT Coronary Angiography Shows Promise In Assessing Cardiac Function Extremely low dose CT coronary angiography can be used to measure cardiac function and has the potential for use when other commonly used examinations are limited, a preliminary study indicates.
Source: www.medicalnewstoday.comHeart Stem Cell Scientist Honored Pioneering Woman Scientist In Keynote Speech Professor Christine Mummery, one of the world's leading heart stem cell experts, honoured the memory of Dame Anne McLaren in the keynote lecture of the inaugural UK National Stem Cell Network Science Meeting in Edinburgh. Dr McLaren was an early pioneer of the study of embryonic germ cells and her research directly contributed to the development of IVF treatments and stem cell techniques.
Source: www.medicalnewstoday.com
# posted by Network @ 7:00 AM
